FDA Class I Drug Recall: Non-Sterile Multi-Action Relief Drops
Rite Aid is recalling Multi-Action Relief Drops nationwide due to non-sterility concerns. The FDA classified this as a Class I recall affecting 9,216 bottles.
What this means for you
Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.
Our severity reasoning: FDA Class I classification requires a Critical score; non-sterility in eye drops presents a significant infection risk.
Plain-English summary
Rite Aid is recalling Multi-Action Relief Drops due to non-sterility concerns. The product contains polyvinyl alcohol 0.5%, providone 0.6%, and tetrahydrozoline hydrochloride 0.05%, packaged in 0.5 FL OZ (15 mL) bottles with NDC 11822-2254-3.
The manufacturer, Kilitch Healthcare India Limited, initiated this Class I recall. A total of 9,216 bottles were distributed nationwide throughout the United States in all lot numbers.
Non-sterile eye drops may pose a risk of serious eye infection. Consumers who have purchased this product should stop using it immediately and seek guidance from their healthcare provider or Rite Aid.
The recalled product
- Product
- Multi-action Relief Drops (Polyvinyl alcohol 0.5%, Providone 0.6%, Tetrahydrozoline Hydrochloride 0.05%), packaged in 0.5 FL OZ (15 mL) bottles, Distributed by: Rite Aid 30 Hunter Lane, Camp Hill, PA 17011, NDC 11822-2254-3
- Manufacturer
- Kilitch Healthcare India Limited
- Category
- Drug — Eye Drops
- Hazard
- non-sterility
- infection-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27